American Journal of Obstetrics & Gynecology
Volume 197, Issue 3, Supplement , Pages S10-S16 , September 2007

Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States

  • Matthew T. McKenna, MD, MPH

      Affiliations

    • Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
    • Northrop Grumman Information Technology, CDC Information Technology Support, Atlanta GA.
    • Corresponding Author InformationReprints: Matthew T. McKenna, MD, MPH, Centers for Disease Control and Prevention, Chief, HIV Incidence and Case Surveillance Branch, 1600 Clifton Road, MS E-47, Atlanta, GA 30333
    • ,
  • Xiaohong Hu, MS

      Affiliations

    • Northrop Grumman Information Technology, CDC Information Technology Support, Atlanta GA.

Received 14 December 2006 ,Accepted 26 February 2007.

References 

  1. Centers for Disease Control and Prevention. Updated Guidelines for Evaluating Public Health Surveillance Systems. MMWR. 2001;50(RR13):1–35
  2. Centers for Disease Control and Prevention. Achievements in public health (Reduction in perinatal transmission of HIV infection: United States, 1985-2005). MMWR Morb Mortal Wkly Rep. 2006;55:592–597
  3. Wortley PM, Lindegren ML, Fleming PL. Successful implementation of perinatal HIV prevention guidelines: a multistate surveillance evaluation. MMWR Recomm Rep. 2001;50:17–28
  4. Centers for Disease Control and Prevention. Enhanced perinatal surveillance: United States, 1999-2001. Atlanta: US Department of Health and Human Services, CDC; 2004;Accessed March 27, 2007. Available at: http://www.cdc.gov/hiv/stats/hasrsupp.htm
  5. US Department of Health and Human ServicesPublic Health Service. Recommendations for use of antiretroviral drugs in pregnant HIV-1–infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Washington (DC): US Department of Health and Human Services, Public Health Service; 2006;Accessed March 27, 2007. Available at http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf
  6. Committee on Pediatric AIDS. Surveillance of pediatric HIV infection. Pediatrics. 1998;101:315–319
  7. Lindegren ML, Byers RH, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA. 1999;282:531–538
  8. Byers RH, Caldwell MB, Davis S, Gwinn M, Lindegren ML. Projection of AIDS and HIV incidence among children born infected with HIV. Stat Med. 1998;17:169–181
  9. Davis SF, Byers RH, Lindegren ML, Caldwell MB, Karon JM, Gwinn M. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA. 1995;274:952–955
  10. Office of Inspector General. Reducing obstetrician barriers to offering HIV testing. Washington (DC): US Department of Health and Human Services, Office of Inspector General; 2002;report no. OEI-05-01-00260. Accessed March 27, 2007. Available at http://oig.hhs.gov/oei/reports/oei-05-01-00260.pdf
  11. Centers for Disease Control and Prevention. HIV prevention: new strategies for a changing epidemic: United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329–332
  12. Centers for Disease Control and Prevention. Revised recommendations for HIV screening of pregnant women. MMWR Morb Mortal Wkly Rep. 2001;50:59–86
  13. Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA. 2006;296:292–300
  14. Institute of Medicine. Measuring what matters: allocation, planning, and quality assessment for the Ryan White CARE Act. Washington (DC): The National Academies Press; 2003;
  15. Nakashima AK, Horsley R, Frey RL, Sweeney PA, Weber JT, Fleming PL. Effect of HIV reporting by name on use of HIV testing in publicly funded counseling and testing programs. JAMA. 1998;280:1421–1426
  16. Nakashima AK, Fleming PL. HIV/AIDS surveillance in the United States, 1981-2001. J Acquir Immune Defic Syndr. 2003;32(suppl):S68–S85
  17. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2004. Atlanta: US Department of Health and Human Services, CDC; 2004;Accessed March 27, 2007. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/past.htm#surveillance
  18. Centers for Disease Control and Prevention. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR 1999;48(No. RR-13). Accessed March 27, 2007. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4813a1.htm.
  19. Borchardt SM, Rawls AW, Benbow N, Dworkin MS. An evaluation of the patient code number for HIV case reporting. Public Health Rep. 2006;121:360
  20. Gerberding JL, Jaffe HW. Dear colleague letter, April 22. Atlanta: US Department of Health and Human Services, CDC; 2003;Accessed March 27, 2007. Available at http://www.cdc.gov/hiv/projects/perinatal/2003/letter.htm
  21. McDavid K, Li J, Lee LM. Racial and ethnic disparities in HIV diagnoses for women in the United States. J Acquir Immune Defic Syndr. 2006;42:101–107
  22. Doyle TJ, Glynn MK, Groseclose SL. Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. Am J Epidemiol. 2002;155:866–874
  23. Hall HI, Song R, Gerstle JE, Lee LM HIV/AIDS Reporting System Evaluation Group. Assessing the completeness of reporting of human immunodeficiency virus diagnoses in 2002-2003: capture-recapture methods. Am J Epidemiol. 2006;164:391–397
  24. Green TA. Using surveillance data to monitor trends in the AIDS epidemic. Stat Med. 1998;17:143–154
  25. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. In: 2nd ed. Boston: PWS-Kent; 1988;
  26. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251–253
  27. Baltussen RM, Hutubessy RC, Evans DB, Murray CJ. Uncertainty in cost-effectiveness analysis: probabilistic uncertainty analysis and stochastic league tables. Int J Technol Assess Health Care. 2002;18:112–119
  28. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995;6:356–365
  29. New York City Department of Health and Mental Hygiene. Pediatric and adolescent HIV/AIDS: surveillance update, New York City; 2005. Accessed March 27, 2007. Available at: http://www.nyc.gov/html/doh/downloads/pdf/dires/ped12-2005.pdf.
  30. Council of State and Territorial Epidemiologists. Surveillance for perinatal HIV exposure. 2002;Atlanta, Ga; Position Statement 02-ID-04. Accessed March 27, 2007. Available at: http://www.cste.org/position%20statements/02-ID-04.pdf.
  31. Glynn MK, Lee LM, McKenna MT. The status of national HIV case surveillance, United States 2006. Pub Health Rep. 2007;122(suppl):63–71

 The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention.

PII: S0002-9378(07)00268-2

doi: 10.1016/j.ajog.2007.02.032

American Journal of Obstetrics & Gynecology
Volume 197, Issue 3, Supplement , Pages S10-S16 , September 2007

Article Tools

* Image Usage & Resolution